Biotricity Inc. (BTCY): Price and Financial Metrics
BTCY Price/Volume Stats
| Current price | $1.35 | 52-week high | $4.78 |
| Prev. close | $1.48 | 52-week low | $0.70 |
| Day low | $1.35 | Volume | 105,400 |
| Day high | $1.48 | Avg. volume | 80,287 |
| 50-day MA | $1.19 | Dividend yield | N/A |
| 200-day MA | $1.58 | Market Cap | 12.72M |
BTCY Stock Price Chart Interactive Chart >
Biotricity Inc. (BTCY) Company Bio
Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.
Latest BTCY News From Around the Web
Below are the latest news stories about BIOTRICITY INC that investors may wish to consider to help them evaluate BTCY as an investment opportunity.
Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call TranscriptBiotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded. And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, […] |
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward positive cashflowRecurring technology fees, customer device sales, remain on an upward trendReduced SG&A to $3.5 million, down 22% compared to same period ... |
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14thBiotricity improves margins while lowering selling expenses and operating lossesREDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in ... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning. |
Biotricity Releases Another Groundbreaking Product: Biotres ProCompany further expands its current product portfolio, making it the most comprehensive Remote Patient and Cardiac Monitoring portfolio globally.Company developed Biotres Pro with critical capability of cellular backup for connectivityRecently filed ... |
BTCY Price Returns
| 1-mo | -4.93% |
| 3-mo | 31.07% |
| 6-mo | -31.30% |
| 1-year | -65.91% |
| 3-year | -90.22% |
| 5-year | -75.14% |
| YTD | 17.39% |
| 2023 | -57.22% |
| 2022 | -88.74% |
| 2021 | 439.08% |
| 2020 | 17.17% |
| 2019 | 31.27% |
Continue Researching BTCY
Want to see what other sources are saying about Biotricity Inc's financials and stock price? Try the links below:Biotricity Inc (BTCY) Stock Price | Nasdaq
Biotricity Inc (BTCY) Stock Quote, History and News - Yahoo Finance
Biotricity Inc (BTCY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...